Due to our rapidly growing business, our success stories were created all over the globe. With our successive flourishing empires in Asia, U.S, U.K, Europe, France and almost every part of the world, we are happy to announce that we are now one of the largest pharmaceutical companies worldwide. In recent years, our industry is in progress of pursuing new potentials through principal investments with various partners.
Our slowly rising financial graph has attracted business proposals from leading marketers in Japan and business pioneers from Australia. Our escalating sales volume continues to take advantage of its potential market presence in New Zealand. We also established powerful active pharmaceutical ingredients (API) facility along with intermediate manufacturing units at our various plants.